Search Main Menu Main Content
  • Change contrast :
Haute Autorité de Santé
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

  • No element in selection

  • Contact

1 result

  • Active substance : clopidogrel
  • Active substance : potassium
  • Topics : Male genital diseases
  • Topics : Urologic diseases
Filter
Topic
  • Economics and public health (1)
  • Plus ...
    • Health economics (1)
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Surgical procedures (1)
    • Plus ...
      • Urogenital surgery (1)
  • Diseases and conditions (1)
  • Plus ...
    • Urologic diseases (1)
    • Plus ...
      • Urination disorders (1)
    • Genital diseases (1)
    • Plus ...
      • Male genital diseases (1)
Content type
  • Drugs, devices and medical acts (1)
  • Plus ...
    • Health technology assessment (1)
Manufacturer
  • inconnu (1)
  • industriels (1)
Language
  • Français (1)
Active substance
  • aluminium (1)
  • aspirine (1)
  • clopidogrel (1)
  • doxazosine (1)
  • lithium (1)
  • mannitol (1)
  • phosphate (1)
  • potassium (1)
  • silodosine (1)
  • tamsulosine (1)

Drugs, devices and medical acts - 1 result

  • Laser treatment of lower urinary tract symptoms associated with benign prostatic

    Health technology assessment - Posted on 12/12/2013
    Télécharger le document
    Add to my selection
Haute Autorité de Santé
Advancing quality in the fields of health and social care services

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
eNq9WN9v2jAQfuevQEjdG4RQIHRLqFp+rEitxgps014ikxwQZuzUdijsr5+TUJFuoWWm7gNSsJ3vLr7P393ZvtyscHENjAeUOCWzUi0VgXjUD8jcKU3G/XKrdNku2Eu0RtllrUrVNVtmqehhxLlTiucrU0CEV37c3XZBIgArtQtFm06X4Iln6yIR4MoN4os7FMZrivaaBn5xBWJBfacURiIZLdpcMOlH+5GyXzxEHtjGbiQ7u3Tr2XHbiMGOQI04sFtE5rmgQJQwvYgxIKKDBMwp2+ZCzzy31rLqF7VzJRMBvwdOI+bBEInFkNF14IOfbwlhDkpGZo/+CNgag4iN5IIbS2/FlcDREm3u4WGQ7/SVnO2IjShXy2bDajQtq1VvVE21GLPMVuWTR36EkUakYVqmAcSQ70RYIFH2oczAWwCTvzIiIvCpKNeq5oVi3IaUCYQ1RSzgnefc02SHwcOrzPADHmK0rSx5qLpViCE5DUwqhL4Pib9gzKRmYblnf+GTCGPjP72e7BRFk8exYHVoRMQBYZmMVDeiQ4mAzeGIqmmh2Oy4GAB/O9jflOTngWE0xYGnKndSkCLgYnI/OKx27yUU14jDhOlTiu8B8ekjf3sFykZck/dhIqK5oCHzTbd20WqajYbyAfsp6XUgM/UiRkMwpDYF/BTJGZAZPVVsJGPzoZ74+i5UTUoo6iEMB4ooV1GTJEefaj5tp0DfCUsnckE/98aq1PkaAduOkr+50IHv7IOuptg60oBk6muex0adD2gVfhKrMEn9jtiGwGdn510h2UoopnMpKWe1/hwIsDhbV3prhCMkZD/SBT7OrOrCSBIbEjwajgBJrqfoqXY4WZ1IxvtXnd7YHU2u3avOePCt53iYhvJkzBng/AUhFbKdCaJVZnp807uTr7rNerNRl656rmnKUFjZZ+vF9c26Va2foIpHtB3nVkvxqLN80V0IEfKPhrFAvMzjfa/MmFqyvNzTQAcV/qXDS5Q4ihZHUEOFHnooItPz/njraxu1lJJpaZ2mZk2uT9Oa63iOq8r4a4Xmqc3T7v1dk5avtyyCE+KQZnxteXnQe/tUv++ctLk9fCbB+swkXU4idroq7Gj6QgJRLi5kYEmfSXX4MpsFB67yDhLTNtJrxHbBNuIrxHbhD1TCzfw=
uahYXRRRC259STgr